Skip to main content
. 2023 Feb 13;2023:1508675. doi: 10.1155/2023/1508675

Table 3.

The difference of clinical, hormonal, and metabolic characteristics between FAI+/FAI- groups in normal weight and obesity/overweight PCOS patents.

Variable Normal weight Obesity/overweight
FAI- (n = 490) FAI+ (n = 35) p FAI- (n = 288) FAI+ (n = 138) p
Age (y) 27.09 ± 3.32 25.54 ± 3.47± 0.008 27.66 ± 3.58 27.47 ± 3.70 0.621
BMI (kg/m2) 20.98 ± 1.65 22.03 ± 1.47 0.0001 27.49 ± 3.04 28.23 ± 3.34 0.023
WHR 0.84 ± 0.07 0.87 ± 0.06 0.015 0.93 ± 0.44 0.91 ± 0.10 0.573
WHtR 47.33 ± 4.41 49.80 ± 4.38 0.001 57.43 ± 5.77 58.87 ± 5.71 0.016
E2 (pmol/l) 157.22 ± 77.69 171.21 ± 79.40 0.304 147.71 ± 80.35 156.74 ± 72.64 0.262
T (nmol/l) 1.10 ± 0.56 1.91 ± 0.64 0.0001 0.97 ± 0.48 1.71 ± 0.52 0.0001
LH/FSH ratio 1.70 ± 1.09 1.85 ± 1.07 0.429 1.30 ± 0.73 1.40 ± 0.67 0.162
SHBG (nmoL/l) 58.84 ± 38.00 19.37 ± 8.67 0.0001 41.04 ± 32.39 18.14 ± 7.15 0.0001
HOMA-IR 2.48 ± 1.61 3.56 ± 2.81 0.0001 4.61 ± 2.68 6.25 ± 3.27 0.0001
FGS (mmol/l) 5.48 ± 0.85 5.42 ± 0.64 0.691 5.91 ± 1.13 6.25 ± 1.25 0.004
F2h (mmol/l) 5.91 ± 1.47 7.03 ± 2.40 0.0001 7.16 ± 2.09 8.04 ± 2.33 0.0001
FIN (μIU/ml) 9.97 ± 5.63 14.74 ± 11.41 0.0001 17.10 ± 8.36 21.93 ± 9.40 0.0001
FI2h (μIU/ml) 70.83 ± 62.70 143.14 ± 147.35 0.0001 119.92 ± 161.40 162.50 ± 99.70 0.004
CHO (mmol/l) 4.17 ± 0.72 4.14 ± 0.68 0.785 5.85 ± 4.92 4.38 ± 0.86 0.485
TG (mmol/l) 1.14 ± 0.93 1.55 ± 1.16 0.014 1.79 ± 1.27 1.93 ± 1.00 0.260
HDL-C (mmol/l) 1.36 ± 0.29 1.30 ± 0.33 0.249 1.16 ± 0.25 1.07 ± 0.19 0.0001
LDL-C (mmol/l) 2.72 ± 7.55 2.38 ± 0.60 0.791 2.78 ± 2.16 2.74 ± 0.73 0.823
LP (a) (mg/l) 146.00 ± 143.74 135.67 ± 120.51 0.682 160.05 ± 192.52 138.4 ± 142.15 0.240
VAI 1.87 ± 2.34 2.85 ± 2.87 0.018 3.39 ± 3.27 4.04 ± 2.66 0.043
LAP 25.57 ± 35.19 42.91 ± 41.28 0.006 66.07 ± 54.79 78.80 ± 61.69 0.031

Note: values are expressed as mean ± SD. FAI: free androgen index; BMI: body mass index; WHR: waist-to-hip ratio; WHtR: waist-to-height ratio; E2: estradiol; T: testosterone; LH: luteinizing hormone; FSH: follicle-stimulating hormone; SHBG: sex hormone-binding globulin; HOMA-IR: homeostasis model assessment-insulin resistance; FGS: fasting glucose; FIN: fasting insulin; F2h: 2-hour postprandial blood glucose; FI2h: 2-hour postprandial blood insulin; CHO: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; LP (a): lipoprotein (a); VAI: visceral adiposity index; LAP: lipid accumulation product.